Bacterial fusion proteins have been used extensively as antigens for the generation of polyclonal antibodies. Because of their larger sizes, fusion proteins usually contain a greater number of potentially immunogenic epitopes than synthetic peptides. Standard methods for the expression and purification of fusion proteins have also added to their appeal. However, these desirable features are frequently counterbalanced by the generation of antibodies directed against the bacterial fusion partner. Although fusion partners vary in size considerably (e.g., 1-2 kDa for histidine tags vs. 27 kDa for glutathione S -transferase [GST]), even smaller tags can be immunogenic and seriously hamper a variety of applications, including immunodetection of target antigens, microinjection of antibodies into cells or in vivo administration. In such cases, immunoaffinity purification can be an effective strategy for the isolation of the desired antibody from the crude immune serum. Although it is possible to immobilize the target antigen by covalent coupling onto several matrices and then bind the antibodies from the crude serum to the immobilized antigen (2), these procedures tend to be laborious and require expensive reagents. Other shortcomings include the inefficiency of the coupling reaction due to the presence of residual detergents or other impurities and ablation of potentially important epitopes. I report a simple, two-step affinity purification technique that uses GST fusion proteins immobilized noncovalently onto glutathione agarose matrices as affinity substrates.
The entire coding sequence of the Fanconi anemia complementation (FAC) group C cDNA was cloned into the BamHI and Eco RI sites of pGEX-2TK (Pharmacia Biotech, Piscataway, NJ, USA) in-frame with the upstream epitope GST as described previously (3) . The resulting plasmid, pGEX-2TK-FAC (predicted to encode a GST-FAC fusion protein of 88 kDa), and the parental plasmid were used to transform Escherichia coli strain HB101. A single colony of transformed bacteria grown overnight at 37°C in 10 mL of LB containing ampicillin (100 µ g/mL) was used to inoculate a 1-L culture medium. After vigorous agitation for approximately 2 h (until the optical density [OD] 600 reached 0.5-0.7), the bacterial culture was induced with isopropyl β -D -thiogalactopyranoside (IPTG; final concentration 0.2 mM) and grown for an additional 4 h at 37°C. Bacteria pelleted by centrifugation (5000 × gfor 10 min) were solubilized in Buffer I (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM β -mercaptoethanol) containing 150 mM NaCl and 1.5% sarkosyl (1-g pellet per 3 mL of buffer). This protocol is a modification of one described previously (1) . The bulk of recombinant GST-FAC was found in inclusion bodies, as demonstrated previously (4) . Although GST alone remained soluble, for methodologic uniformity it was also isolated from IPTG-induced bacteria by the same method. Solubilized lysates were disrupted by sonication with a Branson Sonifier 250 (Branson Instruments, Westbury, NY, USA) for 1 min at power level 5 and duty cycle 50%, clarified by centrifugation at 10 000 ×gfor 15 min, and Triton ® X-100 was added to a final concentration of 2%. A 50% slurry (wt/vol) of glutathione agarose was COS-1 cells were transfected with pcDNA3-FAC and plated on coverslips. After 48 h, cells were fixed with 3% paraformaldehyde and permeabilized with 0.1% Triton X-100 in phosphate-buffered saline. Primary antibodies used were preimmune serum (Panel A; 1:100 dilution), affinity-purified anti-GST antibody (Panel B; 1 µ g/mL), affinity-purified anti-FAC antibody (Panel C; 0.1 µ g/mL) and the fraction of immune serum that did not bind to the GST-FAC matrix after the first pass (Panel D; 1:100 dilution). The secondary antibody was fluorescein-conjugated goat anti-rabbit IgG (Cappel, West Chester, PA, USA). Photomicrographs were obtained at a magnification of 100 × using identical exposure times (12.8 s). prepared according to the suggestions of the manufacturer (Sigma Chemical, St. Louis, MO, USA). Lysates containing GST or GST-FAC fusion proteins were incubated with hydrated glutathione agarose for 1 h by gentle rocking at 4°C. Approximately 0.5 mL of 50% glutathione agarose slurry was incubated with 12 mL of sonicate containing GST-FAC or 3 mL of sonicate containing GST. Bound agarose matrices were then washed successively with Buffer I containing 300 mM NaCl, 300 mM NaCl/15% glycerol and 150 mM NaCl.
Sera from rabbits immunized with solubilized GST-FAC (3) were used for subsequent fractionation experiments. To deplete anti-GST antibodies, 5 mL of crude immune serum were incubated with glutathione agarose coated with GST (ca. 0.5 mg) by end-on rotation for 1 h at 4°C, and the unbound fraction was collected after loading onto a polypropylene column (Bio-Rad, Hercules, CA, USA). The depleted serum was then incubated with GST-FAC (ca. 0.2 mg) immobilized on glutathione agarose for 1 h at 4°C by end-on rotation and loaded onto a polypropylene column, and the column was washed with Buffer I containing 150 mM NaCl until the OD 280 reached <0.003. For elution of antibodies, it was important to maintain the interaction of GST or GST-FAC with the agarose matrix. Preliminary experiments indicated that these interactions were stable at pH 2.8 (data not shown). Hence, the bound antibodies were eluted stepwise with 0.5-mL fractions of 100 mM glycine (pH 2.8) into 50 µ L of 1 M Tris-HCl (pH 8.0) for immediate neutralization. The elution was monitored by spectrophotometry, and the extinction coefficient of IgG was used to estimate the yield of anti-GST or anti-FAC antibodies (an OD 280 of 1.33 is 1 mg/mL of IgG). Finally, glutathione agarose matrices coated with GST-FAC were regenerated by extensive washing in 100 mM Tris-HCl (pH 8.0) containing 150 mM NaCl, and the affinity purification procedure was repeated with an additional 5-mL aliquot of serum depleted of anti-GST antibodies. Figure 1 shows the results of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie ® blue staining of protein fractions. Acid eluates from glutathione agarose coated with GST and GST-FAC showed the expected sizes for the heavy and light chains of IgG (about 55 and 25 kDa, respectively). The total yield of anti-FAC antibodies from the first and second rounds of purification were 1.1 and 0.39 mg, respectively. In other experiments, the yield from the second round of purification was also consistently lower than the first (in the range 31%-44% of the first round).
The functional ability of anti-FAC antibodies was demonstrated by indirect immunofluorescence of COS-1 cells transfected with wild-type FAC cloned in pcDNA3 (pcDNA3-FAC; Invitrogen, Carlsbad, CA, USA). The expected cytoplasmic localization of the protein was observed when cells were incubated with the affinity-purified antibody but not with the preimmune serum or with affinity-purified anti-GST antibodies (Figure 2 ). The specificity and purity of these antibodies were further demonstrated by immunoblotting and immunoprecipitation experiments. The expression of purified GST was significantly greater in IPTGinduced than uninduced lysates by Coomassie blue staining, as expected, as well as by Western blot analysis with anti-GST antibodies ( Figure 3A) . Thus, the anti-GST antibodies prepared by depletion of the immune serum are also capable of detecting the appropriate antigen. It is likely, however, that this preparation contains antibacterial antibodies. In contrast, while affinity-purified anti-FAC antibodies detected two different GST-FAC fusion proteins, these antibodies failed to detect GST ( Figure 3B ). Thus, the anti-FAC antibody preparation can detect the fusion partner of GST and appears to be largely free of anti-GST antibodies. Finally, these antibodies were also evaluated for their ability to immunoprecipitate FAC from transfected COS-1 cells. Incubation of cytosolic lysates successively with anti-FAC antibodies (from both rounds of purification) and protein A agarose (Affi-Gel ® ; Bio-Rad) followed by SDS-PAGE and autoradiography showed the expected 63-kDa antigen ( Figure 3C ). Similar quantities of anti-GST antibodies failed to immunoprecipitate FAC. These data demonstrate that the affinity-purified anti-FAC antibodies are monospecific and bind to soluble FAC in mammalian cells. In summary, this protocol obviates the need for covalent coupling of the antigen to reactive matrices and can be completed in less than one day. The elution conditions preserve the integrity of the antibodies for many applications without the need for dialysis of the elution buffer. Although the subsequent binding capacity of protein-coated glutathione agarose is reduced considerably, affinity-purified antibodies obtained from the second round of purification remain comparable in purity and function to those obtained from the first round.
